Automated red cell exchange procedures in patients with sickle cell disease

Transfusion and Apheresis Science

Volumn 36, Issue 3, 2007, Pages 305-312

  Kozanoglu, Ilknur ^a   Boga, Can ^a   Ozdogu, Hakan ^a   Sezgin, Nurzen ^a   Kizilkilic, Ebru ^a   Kural, Mahmut ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Red cell exchange; Sickle cell disease; Vaso occlusive crisis

Indexed keywords

CITRIC ACID;

ADOLESCENT; ADULT; APHERESIS; ARTICLE; AUTOMATION; BLOOD VESSEL OCCLUSION; ERYTHROCYTE; FEMALE; HUMAN; INFUSION RATE; MAJOR CLINICAL STUDY; MALE; SICKLE CELL ANEMIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ARTERIAL OCCLUSIVE DISEASES; AUTOMATION; BLOOD COMPONENT REMOVAL; CITRIC ACID; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 34447648928     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.03.012     Document Type: Article

References (28)

1. Stuart M.J., and Nagel R.L. Sickle-cell disease. Lancet 364 (2004) 1343-1360
2. Singer S.T., Quirolo K., Nishi K., Hackney-Stephens E., Evans C., and Vichinsky E.P. Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload. J Clin Apher 14 (1999) 122-125
3. McCarthy L.J., Vattuone J., Weidner J., Skipworth E., Fernandez C., Jackson L., et al. Do automated red cell exchanges relieve priapism in patients with sickle cell anemia?. Ther Apher 4 (2000) 256-258
4. Uchida K., Rackoff W.R., Ohene-Frempong K., Kim H.C., Reilly M.P., and Asakura T. Effect of erythrocytapheresis on arterial oxygen saturation and hemoglobin oxygen affinity in patients with sickle cell disease. Am J Hematol 59 (1998) 5-8
5. Sacco R.L., Adams R., Albers G., Alberts M.J., Benavente O., Furie K., et al. American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 113 (2006) e409-e449
6. Hiran S. Multiorgan dysfunction syndrome in sickle cell disease. J Assoc Physicians India 53 (2005) 19-22
7. Idris A.H., Berg R.A., Bierens J., Bossaert L., Branche C.M., Gabrielli A., et al. American Heart Association. Recommended guidelines for uniform reporting of data from drowning: the "Utstein style". Circulation 108 (2003) 2565-2574
8. Rosse W.F., Telen M., and Ware R. Transfusion support for patients with sickle cell disease (1998), American Association of Blood Banks, Bethesda, MD
9. Ware J.E., Snow K.K., Kosinski M., and Gandek B. SF 36 health survey manual and interpretation guide (1993), Nimrod Press, Boston, Mass
10. Cortas N.K., and Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36 (1990) 1440-1443
11. Kocak R., Alparslan Z.N., Agridag G., Baslamisli F., Aksungur P.D., and Koltas S. The frequency of anaemia, iron deficiency, hemoglobin S and beta thalassemia in the south of Turkey. Eur J Epidemiol 11 (1995) 181-184
12. Wanko S.O., and Telen M.J. Transfusion management in sickle cell disease. Hematol Oncol Clin North Am 19 (2005) 803-826 v-vi
13. Bruce C M. Apheresis principles and practice. 2nd ed. (2003), AABB Press, Bethesda, Md
14. Eckman J.R. Techniques for blood administration in sickle cell patients. Semin Hematol 38 (2001) 23-29
15. Kim H.C., Dugan N.P., Silber J.H., Martin M.B., Schwartz E., Ohene-Frempong K., et al. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 83 (1994) 1136-1142
16. Hilliard L.M., Williams B.F., Lounsbury A.E., and Howard T.H. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients. Am J Hematol 59 (1998) 28-35
17. Nifong T.P., and Domen R.E. Oxygen saturation and hemoglobin A content in patients with sickle cell disease undergoing erythrocytapheresis. Ther Apher 6 (2002) 390-393
18. Ergul S., Brunson C.Y., Hutchinson J., Tawfik A., Kutlar A., Webb R.C., et al. Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction. Am J Hematol 76 (2004) 245-251
19. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., Cannon III R.O., Schechter A.N., et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8 (2002) 1383-1389
20. Altintas E., Tiftik E.N., Ucbilek E., and Sezgin O. Sickle cell anemia connected with chronic intrahepatic cholestasis: a case report. Turk J Gastroenterol 14 (2003) 215-218
21. Lee W., Werch J., Rokey R., Pivarnik J., and Miller J. Physiologic observations of pregnant women undergoing prophylactic erythrocytapheresis for sickle cell disease. Transfusion 31 (1991) 59-62
22. Lombardo T., Rosso R., La Ferla A., Ferro M.G., Ximenes B., Frontini V., et al. Acute Chest Syndrome: the role of erythro-exchange in patients with sickle cell disease in Sicily. Transfus Apher Sci 29 (2003) 39-44
23. Cabibbo S., Fidone C., Garozzo G., Antolino A., Manenti G.O., Bennardello F., et al. Chronic red blood cell exchange to prevent clinical complications in sickle cell disease. Transfus Apher Sci 32 (2005) 315-321
24. Vichinsky E.P., Styles L.A., Colangelo L.H., Wright E.C., Castro O., and Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative study of sickle cell disease. Blood 89 (1997) 1787-1792
25. Telen M.J. Principles and problems of transfusion in sickle cell disease. Semin Hematol 38 (2001) 315-323
26. Howard R.J., Tuck S.M., and Pearson T.C. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome. Brit J Obstet Gynaecol 102 (1995) 947-951
27. Adams R.J. Stroke prevention and treatment in sickle cell disease. Arch Neurol 58 (2001) 565-568
28. Scothorn D.J., Price C., Schwartz D., Terrill C., Buchanan G.R., Shurney W., et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 140 (2002) 348-354